Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)

NCT07500025 is registered in ClinicalTrials.gov with Feldman Cardiology, PLLC as lead sponsor.

NCT NCT07500025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07500025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)
Lead sponsor
Feldman Cardiology, PLLC
Phase
Observational
Overall status
Not yet recruiting
Start date
July 10, 2027
Completion date
July 10, 2028
Enrollment
8 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation (tr)